Postoperative radiotherapy following null-margin hepatectomy in patients with hepatocellular carcinoma adhering to the major vessels: A propensity score-matched survival analysis cohort study

被引:0
|
作者
Long, Liuhua [1 ,2 ]
Chen, Bo [2 ]
Zheng, Xuan [1 ]
Wu, Fan [3 ]
Wang, Liming [3 ]
Rong, Weiqi [3 ]
Wu, Jianxiong [3 ]
Li, Yexiong [2 ]
Wang, Weihu [1 ]
机构
[1] Peking Univ Canc Hosp & Inst, Dept Radiat Oncol, Key Lab Carcinogenesis & Translat Res, Minist Educ Beijing, Beijing, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Natl Clin Res Ctr Canc, State Key Lab Mol Oncol,Canc Hosp,Dept Radiat Onco, Beijing, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Natl Clin Res Ctr Canc, Dept Hepatobiliary Surg,Canc Hosp, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
Hepatocellular carcinoma; Null -Margin hepatectomy; Postoperative radiotherapy; Propensity score; Prognosis; Recurrence; LIVER RESECTION;
D O I
10.1016/j.ctro.2024.100727
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background & Aims: This study aims to analyze the prognosis of null-margin (<= 1.0 mm) hepatectomy (NH) in patients with hepatocellular carcinoma (HCC) adhering to the major vessels and explore the value of postoperative radiotherapy (RT) in these patients. Methods: HCC patients who underwent null-margin or wide-margin (>= 1.0 cm) hepatectomy (WH) by our team from January 2008 to March 2016 were recruited and analyzed retrospectively. The patients were divided into the NH, NH + RT, and WH groups. Propensity score matching (PSM) was performed to balance baseline characteristics. Results: A total of 357 patients were recruited. Of these, 84, 49, and 224 patients were given NH alone, NH plus RT, and WH, respectively. After PSM, the 5-year overall survival (OS) and disease-free survival (DFS) rates of the NH group were significantly worse than those of the WH group (51.5 % vs. 71.4 %, P = 0.003; 32.2 % vs. 50.9 %, P = 0.005). The OS and DFS rates of the NH + RT group were significantly higher than those of the NH group (75.6 % vs. 56.1 %, P = 0.012; 46.6 % vs. 30.2 %, P = 0.015) and similar to those of the WH group (75.6 % vs. 75.1 %, P = 0.354; 46.6 % vs. 56.6 %, P = 0.717). In addition, patients in the NH + RT group experienced significantly lower early (P = 0.023) and intrahepatic (P = 0.015) recurrences than those in the NH group. Conclusions: Patients with HCC adhering to the major vessels who underwent NH alone had a poorer prognosis, and the addition of RT to NH provide a significant survival benefit for these patients, which may yield outcomes comparable to the efficacy of WH.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Survival benefit of radiotherapy following narrow-margin hepatectomy in patients with hepatocellular carcinoma: A propensity score-matched analysis based on phase II study
    Long, Liuhua
    Chen, Bo
    Wang, Hongzhi
    Zhao, Yuting
    Wu, Fan
    Wang, Liming
    Rong, Weiqi
    Wu, Jianxiong
    Li, Yexiong
    Wang, Weihu
    RADIOTHERAPY AND ONCOLOGY, 2023, 180
  • [2] Outcomes following laparoscopic versus open major hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a propensity score-matched analysis
    Xu, Hong-wei
    Liu, Fei
    Li, Hong-yu
    Wei, Yong-gang
    Li, Bo
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2018, 32 (02): : 712 - 719
  • [3] Outcomes following laparoscopic versus open major hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a propensity score-matched analysis
    Hong-wei Xu
    Fei Liu
    Hong-yu Li
    Yong-gang Wei
    Bo Li
    Surgical Endoscopy, 2018, 32 : 712 - 719
  • [4] Prognostic analysis and limited efficacy of adjuvant TACE in hepatocellular carcinoma following hepatectomy: a propensity score-matched study
    Peng, Yi
    Shen, Shuang
    Feng, Yifei
    Wen, Zhaochan
    Qin, Jiayin
    Lu, Wei
    Xiang, Bangde
    LANGENBECKS ARCHIVES OF SURGERY, 2025, 410 (01)
  • [5] Salvage Hepatectomy for Recurrent Hepatocellular Carcinoma after Radiofrequency Ablation: A Retrospective Cohort Study with Propensity Score-Matched Analysis
    Park, Yeshong
    Han, Ho-Seong
    Yoon, Yoo-Seok
    Yoon, Chang Jin
    Lee, Hae Won
    Lee, Boram
    Kang, Meeyoung
    Kim, Jinju
    Cho, Jai Young
    CANCERS, 2023, 15 (19)
  • [6] Pure laparoscopic vs open right hepatectomy in patients with hepatocellular carcinoma: A propensity score-matched analysis
    Nam, Yi-Yeon
    Hong, Suk Kyun
    Hong, Su Young
    Lee, Sola
    Choi, YoungRok
    Yi, Nam-Joon
    Lee, Kwang-Woong
    Suh, Kyung-Suk
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2023, 30 (03) : 293 - 302
  • [7] Hepatectomy Combined with Diaphragmatic Resection for Hepatocellular Carcinoma with Diaphragmatic Involvement: A Propensity Score-Matched Analysis
    Tatsuya Orimo
    Toshiya Kamiyama
    Kenji Wakayama
    Shingo Shimada
    Akihisa Nagatsu
    Yoh Asahi
    Yuzuru Sakamoto
    Hirofumi Kamachi
    Akinobu Taketomi
    Annals of Surgical Oncology, 2020, 27 : 4153 - 4163
  • [8] Hepatectomy Combined with Diaphragmatic Resection for Hepatocellular Carcinoma with Diaphragmatic Involvement: A Propensity Score-Matched Analysis
    Orimo, Tatsuya
    Kamiyama, Toshiya
    Wakayama, Kenji
    Shimada, Shingo
    Nagatsu, Akihisa
    Asahi, Yoh
    Sakamoto, Yuzuru
    Kamachi, Hirofumi
    Taketomi, Akinobu
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (11) : 4153 - 4163
  • [9] Survival benefit with IMRT following narrow-margin hepatectomy in patients with hepatocellular carcinoma close to major vessels
    Wang, Wei-Hu
    Wang, Zhi
    Wu, Jian-Xiong
    Zhang, Tao
    Rong, Wei-Qi
    Wang, Li-Ming
    Jin, Jing
    Wang, Shu-Lian
    Song, Yong-Wen
    Liu, Yue-Ping
    Ren, Hua
    Fang, Hui
    Wang, Wen-Qing
    Liu, Xin-Fan
    Yu, Zi-Hao
    Li, Ye-Xiong
    LIVER INTERNATIONAL, 2015, 35 (12) : 2603 - 2610
  • [10] Chemotherapeutic perfusion of portal vein after tumor thrombectomy and hepatectomy benefits patients with advanced hepatocellular carcinoma: A propensity score-matched survival analysis
    Gao, Yang
    Wang, Peng-Xiang
    Cheng, Jian-Wen
    Sun, Yun-Fan
    Hu, Bo
    Guo, Wei
    Zhou, Kai-Qian
    Yin, Yue
    Li, Yuan-Cheng
    Wang, Jian
    Huang, Jun-Feng
    Qiu, Shuang-Jian
    Zhou, Jian
    Fan, Jia
    Yang, Xin-Rong
    CANCER MEDICINE, 2019, 8 (16): : 6933 - 6944